Poseida Therapeutics, Inc.

GOLDMAN SACHS GROUP INC

Report date

12/31/2024

Quarter

2024 Q4

Filed

2/11/2025

Shares

322,060

Value ($000)

3,092

Weight

0.0%

2020 Q3 - 2024 Q4 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q4	2/11/2025	3,092	0.0%	322,060	12/31/2024
2024 Q3	11/14/2024	1,737	0.0%	607,358	9/30/2024
2024 Q2	8/13/2024	1,465	0.0%	501,860	6/30/2024
2024 Q1	5/15/2024	1,437	0.0%	450,517	3/31/2024
2023 Q4	5/14/2024	1,582	0.0%	470,972	12/31/2023
2023 Q3	5/15/2024	1,112	0.0%	467,101	9/30/2023
2023 Q2	5/14/2024	439	0.0%	249,592	6/30/2023
2023 Q1	5/14/2024	904	0.0%	293,362	3/31/2023
2022 Q4	5/14/2024	682	0.0%	128,713	12/31/2022
2022 Q3	5/14/2024	262	0.0%	74,144	9/30/2022
2022 Q2	5/14/2024	116	0.0%	44,715	6/30/2022
2022 Q1	5/16/2022	253	0.0%	56,477	3/31/2022
2021 Q4	2/17/2022	531	0.0%	77,932	12/31/2021
2021 Q3	1/20/2022	416	0.0%	57,175	9/30/2021
2021 Q2	8/13/2021	345	0.0%	34,457	6/30/2021
2021 Q1	5/17/2021	375	0.0%	39,249	3/31/2021
2020 Q4	2/12/2021	461	0.0%	42,025	12/31/2020
2020 Q3	11/13/2020	322	0.0%	36,272	9/30/2020